4.8.8.1Vertical

Deep Brain Stimulation (DBS) Systems

Implantable neurostimulation systems treating Parkinson's and tremor.

Market snapshot

These figures describe Neurological & Neuromodulation Devices (4.8.8), the segment that Deep Brain Stimulation (DBS) Systems sits within. They are not figures for Deep Brain Stimulation (DBS) Systems on its own.

FragmentationConsolidatedEstimate

Within electromedical apparatus (NAICS 334510); the Census Bureau does not split out neuromodulation, so the segment is not separately sized.

Business model & economics

Revenue model

Implantable device sales plus replacement and programming

Key economics

Recurring revenue
Moderate

replacement-cycle-driven

EBITDA margin
20–30%
Capex intensity
High

Characteristics

  • Chronic-pain and movement-disorder applications.
  • Expanding neuromodulation indications.
  • Implantables with replacement-cycle revenue.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Neuromodulation strategics
  • Diversified medtech platforms
  • VC-backed innovators

What’s driving deals

  • Acquisition of neuromodulation innovation.
  • Expanding indications and chronic-pain demand.
  • High-value implantable economics.

Find Deep Brain Stimulation (DBS) Systems acquisition targets

Search Acquisera’s index for companies classified under Deep Brain Stimulation (DBS) Systems (4.8.8.1) and build a targeted deal pipeline.

Search companies